Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polidocanol Sclerotherapy for OSA and Snoring
NCT00399451Phase 2Unknown
- Sponsor
- Liaoyang Central Hospital
- Start
- Dec 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of 10XB101 in obstructive sleep apnea (OSA), primary snoring, sponsored by Liaoyang Central Hospital. Status: unknown.
02
Drugs
10XB101
03
Conditions
obstructive sleep apnea (OSA)primary snoring
Beyond the preview
Go deeper on NCT00399451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399451.